Home / Health / Eczema Cream Recalled: Potential Staph Contamination
Eczema Cream Recalled: Potential Staph Contamination
14 May
Summary
- Eczema cream recalled due to Staphylococcus aureus contamination.
- Product sold nationwide and online, including Amazon.
- Stop using cream immediately and discard safely.
Pharmaçal has initiated a recall for its Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, commonly known as MG217, after discovering contamination with Staphylococcus aureus. This bacteria can lead to serious or life-threatening infections, particularly for individuals with compromised skin or weakened immune systems. The FDA issued the announcement on Tuesday, May 12.
The recalled product, sold in 6 oz. tubes (product code 5106, UPC 012277051067, lot 1024088, expires November 2026), was available nationwide through wholesale and retail channels, as well as online platforms like Amazon. Pharmacal has not yet reported any adverse events linked to this recall.
Consumers who have purchased the affected eczema cream are strongly advised by the FDA to cease using it immediately and to dispose of it securely. Pharmacal is coordinating with distributors for the return of all recalled items. For inquiries, customers can contact Pharmacal directly. Concerns about adverse reactions should be reported to the FDA's MedWatch program.
